Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer


Platinum-based chemotherapy is the recommended first-line treatment for high-grade serous (HGS) epithelial ovarian cancer (EOC). However, most patients relapse because of platinum refractory/resistant disease. We aimed at assessing whether other drugs, commonly used to treat relapsed HGS-EOC and poorly active in this clinical setting, might be more… (More)
DOI: 10.18632/oncotarget.8325